Genomic testing in premature ovarian insufficiency: proceed with caution

Area of Science:

• Reproductive Medicine
• Genetics
• Genomic Medicine

Background:

• Genomic testing shows potential to improve outcomes for women with infertility.
• Premature ovarian insufficiency (POI) is a key condition where genomic testing could be beneficial.
• Widespread diagnostic use of genomic testing for POI is increasingly advocated.

Purpose of the Study:

• To outline the benefits of genomic testing for premature ovarian insufficiency (POI).
• To highlight overlooked concerns regarding the clinical implementation of genomic testing for POI.
• To address the complexities and potential pitfalls in transitioning genomic testing from research to clinical practice.

Main Methods:

• Review of current research literature on genomic testing for POI.
• Analysis of variant curation practices in genomic studies.
• Discussion of clinical translation challenges and ethical considerations.

Main Results:

• Existing literature often employs inadequate variant curation, leading to potentially inflated diagnostic claims.
• The complexities of genomic testing for POI are not sufficiently addressed in current research.
• Inaccurate diagnoses and a lack of appreciation for broader implications are risks without careful clinical transition.

Conclusions:

• Genomic testing holds significant promise for diagnosing and managing POI.
• Improved variant curation and rigorous validation are crucial for reliable genomic testing.
• Careful consideration of ethical and practical implications is necessary for successful clinical integration of genomic testing for POI.